Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.

[1]  F. Locatelli,et al.  T lymphocytes of recipient origin may contribute to the recovery of specific immune response toward viruses and fungi in children undergoing cord blood transplantation. , 2004, Blood.

[2]  R. Maserati,et al.  Evaluation of infectious complications and immune recovery following high-dose chemotherapy (HDC) and autologous peripheral blood progenitor cell transplantation (PBPC-T) in 148 breast cancer patients. , 2002, Anticancer research.

[3]  G. Bastert,et al.  Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow , 2001, Nature Medicine.

[4]  G. Bastert,et al.  Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients , 2001, International journal of cancer.

[5]  R. Collins,et al.  Assessment of thymic output in adults after haematopoietic stemcell transplantation and prediction of T-cell reconstitution , 2000, The Lancet.

[6]  C. Mackall.  T‐Cell Immunodeficiency Following Cytotoxic Antineoplastic Therapy: A Review , 2000, The oncologist.

[7]  E. Lanino,et al.  Total-body irradiation and melphalan is a safe and effective conditioning regimen for autologous bone marrow transplantation in children with acute myeloid leukemia in first remission. The Italian Association for Pediatric Hematology and Oncology-Bone Marrow Transplantation Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Opez,et al.  Quantitative and qualitative alterations of long‐term culture‐initiating cells in patients with acute leukaemia in complete remission , 1998, British journal of haematology.

[9]  D. Rubinstein,et al.  Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. , 1998, Blood.

[10]  N. Gorin.  Autologous stem cell transplantation in acute myelocytic leukemia. , 1998, Blood.

[11]  D. Niederwieser,et al.  Essential role of the thymus to reconstitute naive (CD45RA+) T-helper cells after human allogeneic bone marrow transplantation. , 1997, Blood.

[12]  A. Lanzavecchia,et al.  Restricted TCR repertoire and long-term persistence of donor-derived antigen-experienced CD4+ T cells in allogeneic bone marrow transplantation recipients. , 1996, Journal of immunology.

[13]  P. Dellabona,et al.  An improved PCR-heteroduplex method permits high-sensitivity detection of clonal expansions in complex T cell populations. , 1996, Journal of immunological methods.

[14]  C. Mackall,et al.  Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. , 1996, Journal of immunology.

[15]  B. Chapuis,et al.  Analysis of T-cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T-cell depleted and unmanipulated grafts. , 1996, Blood.

[16]  M. Labopin,et al.  One hundred twenty-five adult patients with primary acute leukemia autografted with marrow purged by mafosfamide: a 10-year single institution experience. , 1994, Blood.

[17]  A. Shad,et al.  Lymphocyte depletion during treatment with intensive chemotherapy for cancer. , 1994, Blood.

[18]  G. Boland,et al.  Evidence for transfer of cellular and humoral immunity to cytomegalovirus from donor to recipient in allogeneic bone marrow transplantation , 1992, Clinical and experimental immunology.

[19]  S. Kato,et al.  Studies on transfer of varicella-zoster-virus specific T-cell immunity from bone marrow donor to recipient. , 1990, Blood.

[20]  L. Lum.  The kinetics of immune reconstitution after human marrow transplantation. , 1987, Blood.

[21]  S. Man,et al.  Limiting dilution analysis of human T cells: a useful clinical tool. , 1990, Immunology today.